跳至主要内容
临床试验/NL-OMON25768
NL-OMON25768尚未招募不适用

The impact of 18 weeks of chemotherapy-treatment with Taxotere/Adriamycin/Cyclophosphamide (TAC) on skeletal muscle composition of female breast cancer patients.

Maxima Medisch Centrum, Veldhoven0 个研究点目标入组 13 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
13

研究概览

简要总结

/A

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Female breast cancer patients;
  • 2. Age between 30-65 years;

排除标准

  • 1. Participation in an exercise rehabilitation program during the study;
  • 2. Chronic diseases that influence skeletal muscle characteristics, like type II diabetes mellitus, chronic obstructive pulmonary disease, chronic heart failure;

研究者

发起方
Maxima Medisch Centrum, Veldhoven

相似试验